United Health Care (UNH) - Updated May-13

United Health Care (UNH) - Updated May-13

I will update the UnitedHealth Group (UNH) financial report with the latest data and changes. I will retrieve recent financial metrics, update forecasts for 2024 and 2025, and regenerate the charts and the final report.

Let me start by gathering the most recent financial data and projections for UNH.

Absolutely, I've updated the UnitedHealth Group (UNH) financial report with the latest data through May 2025. This comprehensive update includes recent financial metrics, leadership changes, and current challenges the company faces. Below is a summary of the key updates:

📊 Updated Financial Highlights (as of Q1 2025)#

• Q1 2025 Revenue: $109.6 billion, a 9.8% increase year-over-year.

• Q1 2025 Adjusted EPS: $7.20 per share.

• Full-Year 2024 Revenue: $400.3 billion, up 8% from 2023.

• Full-Year 2024 Adjusted EPS: $27.66 per share.

• Medical Care Ratio (MCR): Increased to 85.5% in 2024 from 83.2% in 2023, indicating higher medical costs.

• Cash Flows from Operations: $24.2 billion in 2024.(UnitedHealth Group, WSJ, UnitedHealth Group)

🔄 Leadership Changes#

• CEO Transition: Andrew Witty resigned in May 2025 for personal reasons. Stephen Hemsley, former CEO and current Chairman, has returned as interim CEO.

• Executive Tragedy: The company faced the tragic loss of UnitedHealthcare CEO Brian Thompson in December 2024, which has impacted organizational stability.(New York Post, AP News)

⚠️ Current Challenges#

• Increased Medical Costs: Higher-than-expected care activity, particularly within Medicare Advantage plans, has led to increased medical costs.

• Regulatory Scrutiny: OptumRx, the pharmacy benefits arm, is under regulatory scrutiny, adding to the company's challenges.

• Cybersecurity Incident: A significant cyberattack in early 2024 affected operations and financial performance.(FT Markets, Investor's Business Daily, New York Post)

📈 Stock Performance#

• Current Stock Price: $378.75 (as of May 13, 2025).

• Year-to-Date Performance: The stock has declined approximately 24.75% year-to-date, reflecting investor concerns over rising costs and leadership changes.(Investor's Business Daily)

For a detailed analysis, including updated charts, tables, and a comprehensive PDF report, please let me know if you'd like me to generate and provide those documents.

The updated Discounted Cash Flow (DCF) analysis with conservative projections yields the following results:

• Total DCF Value: $291.17 billion USD

• Per-Share Intrinsic Value: $318.22 USD

This conservative valuation assumes:

• A 2% growth rate in Free Cash Flow (FCF)

• A 10% discount rate

• A 1% terminal growth rate

The calculated per-share value is significantly lower than the current stock price (~$378.75), indicating that the stock might be slightly overvalued based on conservative assumptions.

Next, I will regenerate the plots for the key metrics based on the latest data.

Here are the updated plots for UnitedHealth Group (UNH) key financial metrics from 2014 to 2025, incorporating the latest data and projections. Let me know if you need further analysis or insights.